CNR1 and migraine disorder: It would be interesting to explore whether migraine, anxiety and sleep disorders in patients with rare deleterious variants in CNR1 could be alleviated by treatment with CB1 agonists that could effectively stimulate the impaired and/or remaining functional CB1 receptors.